Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 06.02.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, ITALY, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. [ … ]
Tue, 06.02.2024
Aurubis AG
Aurubis achieves strong Q1 2023/24 result
€ 111 in operating EBT driven by rises in treatment and refining charges and the cathode premium along with good demand for wire rod in Q1 2023/24
Significantly expanded investment for realizing growth strategy in Q1
Commissioning of the US recycling plant scheduled to start by the end of the current fi [ … ]
Tue, 06.02.2024
YOC AG
YOC AG: FINANCIAL YEAR 2023 WITH REVENUE GROWTH OF 31% AND EXPANSION OF PROFITABILITY BASED ON PRELIMINARY FIGURES
VIS.X® technology platform as the driver of the company's development
Increase in revenue to EUR 30.6 million (2022: EUR 23.4 million)
EBITDA of EUR 4.3 million (2022: EUR 3.5 million)
Q4/2023 with a revenue growth of around 3 [ … ]
Tue, 06.02.2024
Implenia AG
Implenia AG
/ Key word(s): Incoming Orders
Implenia wins large, complex civil engineering and building construction projects in Switzerland and Germany
06.02.2024 / 07:00 CET/CEST
Motorway refurbishment between Thun Süd and Spiez | Renovation of city motorway between St. Gallen West and East | Focus on improving safety, [ … ]
Tue, 06.02.2024
Ringmetall SE
Ringmetall more confident about 2024 after a challenging 2023
Preliminary Group revenue for 2023 down -15.0 percent to EUR 181.4 million
Preliminary EBITDA of EUR 17.9 million down -36.6 percent on previous year, also due to one-off deconsolidation effects of EUR -4.6 million from sale of HSM
Guidance 2024 highlights opportunities in current fi [ … ]
Tue, 06.02.2024
Berentzen-Gruppe Aktiengesellschaft
Press Release No. 2/2024
Berentzen-Gruppe Aktiengesellschaft publishes preliminary results
Revenue and earnings targets fully achieved in financial year 2023
Consolid [ … ]
Tue, 06.02.2024
Tron DAO
NEWS RELEASE BY TRON DAO
Download PDFDownload multimedia
Geneva, Switzerland | February 05, 2024 03:07 PM Eastern Standard Time
Geneva, Switzerland / February 05, 2024 / - The TRON network has been analyzed in reports by Messari and Reflexivity Research, highlighting its significant role and technological advancements in the block [ … ]
Mon, 05.02.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, February 5, 2024
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
Tafasitamab sold to Incyte
Novartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of
€ 68.00 per share in cash
Shareholders benefi [ … ]
Mon, 05.02.2024
MorphoSys AG
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014
Planegg/Munich, Germany, February 5, 2024
Ad hoc: MorphoSys AG Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value and into Purchase Agreement with Incyte for the Sale of Tafasitamab
M [ … ]
Mon, 05.02.2024
CropEnergies AG
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY OTHER JURISDICTION WHERE TO DO SO WOULD VIOLATE THE LAWS OF SUCH JURISDICTION
Delisting is expected to become effective by the end of February 2024
Mannheim, 5 February 2024 – CropEnergies AG, Mannheim, (“CropEnergies“) plans to withdraw from the stock exchange [ … ]